Articles tagged with Obesity
A study published by the European Association for the Study of Obesity found that women are significantly more aware of and have a better understanding of obesity drugs like semaglutide and tirzepatide. Understanding tolerable side effects, effectiveness, and ability to maintain weight loss is crucial for people commencing treatment.
A study published in JAMA Neurology found that GLP-1RAs and SGLT2is may have neuroprotective effects for people with Type 2 diabetes and those without diabetes. These findings suggest that these medications may slow the rate of cognitive decline in Alzheimer’s patients.
A new study published in The Journal of Internal Medicine found that having an unhealthy metabolic profile increases the risk of breast cancer recurrence by 69% and subsequent breast cancer mortality by 83% among survivors. This association was consistent across Europe, North America, and Asia.
The 2025 Bray Obesity Symposium provides valuable insights and guidance from leading researchers in obesity medicine. The symposium features topics such as advances in obesity genetics, pediatric obesity, lifestyle intervention, and pharmacotherapy.
Adverse pregnancy outcomes like gestational diabetes and high blood pressure contribute significantly to cardiovascular disease risk factors in midlife. Prioritizing weight management among those considering pregnancy may promote both maternal and future cardiovascular health.
The research aims to bridge the translational gap between animal and human studies, exploring how obesity impacts decision-making around food. The team will measure brain chemical activity while participants consume sugary drinks and complete emotion-related tasks.
A new American Heart Association scientific statement emphasizes the importance of multidimensional sleep health in reducing cardiometabolic risks. The statement reviews evidence on the relationship between sleep and various health factors, including body fat, blood sugar, cholesterol, and blood pressure.
A new analysis of the SURMOUNT-1 trial found that around two-thirds of participants regained only 5% or less of their lowest weight over three years. The study suggests that most patients receiving tirzepatide had a relatively stable weight journey, with limited weight regain after reaching their nadir weight.
A new study found that tirzepatide can produce sustained weight loss of up to 31% in adults with overweight or obesity without diabetes, regardless of age or BMI. The study also identified patterns of weight loss trajectories and found that females and those without obesity-related complications may be more responsive to the medication.
Researchers developed a dual-action nanotherapy that converts white fat into beige fat and reduces obesity-related inflammation, significantly improving metabolic health without detectable toxicity.
A comprehensive longitudinal analysis of obesity trajectories identified distinct patterns affecting brain morphology, function, and cognition in middle-aged and older adults. The study suggests sustained obesity accelerates brain aging, highlighting the clinical importance of long-term monitoring and management.
A new study found that both employed people with obesity and employer representatives acknowledge the impact of obesity on future health problems and perceive lifestyle change alongside anti-obesity medications as the most effective approach for maintaining weight-loss reduction. Cost of medication coverage remains a significant barrie...
A six-month study found that patients using GLP-1 and dual GLP-1/GIP receptor agonist therapy experienced minimal lean muscle mass loss as they lost weight. Regular resistance training, consistent protein intake, and close supervision by an expert obesity doctor were associated with better muscle retention.
A new study by the University of Surrey found that restricting carbohydrates can lead to improvements in metabolic markers and better handling of high-fat meals. This approach may be more sustainable than extreme calorie restriction, reducing hunger and increasing energy burning.
Researchers at Weill Cornell Medicine found that decreased ceramide levels in blood vessels can cause chronic illnesses. Ceramides regulate blood vessel tone and prevent blood clots, but low levels increase inflammation, high blood pressure, and glucose levels, leading to cardiometabolic conditions.
A study found that migrants experience a 'clear change' in their gut microbiome composition after migration, leading to increased rates of cardiovascular disease. The Amsterdam UMC-led research showed that specific groups of microbes disappear or emerge along the migration axis.
The Endocrine Society strongly disagrees with the administration's decision not to finalize a rule allowing Medicare and Medicaid to cover anti-obesity medications. This decision leaves millions of Americans with obesity without access to evidence-based treatment, exacerbating the country's growing obesity epidemic.
The American College of Physicians has awarded $260,000 in grants to support regional programs addressing equity challenges in obesity care. Thirteen grantees will implement collaborative outreach projects to train medical professionals and their patients to combat misinformation and improve clinical capacity for obesity care.
Researchers found that people's activity patterns and visit frequency at healthy food sources are stronger predictors of obesity-related cancer risk than location-based approaches. The study used GPS data and obesity-related cancer mortality data to analyze the relationship between food shopping habits and health outcomes.
A new review of studies on percentage weight-based targets in obesity interventions found that these targets often result in a 'success or failure' outcome, leaving little room for improvement in obesity-related complications, quality of life, and overall physical and social functioning. The study recommends shifting focus towards more...
A recent NIH-funded study found that rural adults experience higher rates of heart disease and its risk factors compared to urban counterparts. The study revealed that variables such as poverty, education, and access to healthcare do not explain these differences, with lifestyle risk factors like smoking also playing a lesser role.
A randomized clinical trial found that 4:3 intermittent fasting resulted in modestly greater weight loss over 12 months compared to daily caloric restriction. The study showed improved cardiometabolic outcomes, including lower blood pressure and cholesterol levels, suggesting that fasting may be a more effective approach for weight loss.
A study found that only a quarter of mental health providers correctly diagnosed bulimia nervosa, with common misdiagnoses including binge eating disorder. Excessive exercise is often overlooked as a compensatory strategy used by people with bulimia.
The SUMMIT trial shows tirzepatide reduces the risk of cardiovascular death or worsening heart failure in patients with obesity, chronic kidney disease, and heart failure, while improving kidney function. Researchers found significant improvements in both patient groups with and without chronic kidney disease.
A new medical database automatically compiles patient records of obese individuals, offering insights for health promotion and drug development. The J-ORBIT database reveals strong links between obesity and various diseases, including diabetes, hypertension, and coronary heart disease.
A new white paper finds that expanding access to anti-obesity medications can prevent or delay chronic disease by years, providing significant societal benefits. The study estimates a $10 trillion return on investment and 13% annual returns on investment for society.
A study found that consuming sucralose alters brain activity related to hunger and increases appetite, especially in people with obesity. The sugar substitute changes how the hypothalamus communicates with other brain regions, including those involved in motivation, potentially leading to cravings and eating behavior changes.
A high-fat diet reduces neurotensin, a brain peptide that interacts with the dopamine network, leading to reduced pleasure in eating. Boosting neurotensin levels restores pleasure and promotes weight loss in mice, offering new avenues for addressing obesity.
A large majority of older Americans believe health insurance – including Medicare – should cover anti-obesity medications. Nearly 37% of respondents met the criteria for overweight and 36% for obesity. Medicare currently covers a drug used for weight management but only in people with diabetes or a history of heart attack or stroke.
A new study found that high sodium intake is linked to a higher risk of both general and abdominal obesity in Finnish adults. The study showed that participants with high dietary sodium intake or high urine sodium concentration were more likely to have general or abdominal obesity.
A study published in Nutrients found that men and women eat differently, with women taking longer to finish meals and chewing more. Increasing the number of chews per bite and taking smaller bites can extend meal duration, which is positively associated with reduced food consumption.
A new study reveals how hunger influences dietary decisions by prioritizing tastiness over healthiness, leading to poorer nutritional choices. Researchers used eye-tracking technology and computational modeling to demonstrate that hungry individuals focus more on the visual appeal of food options and ignore nutritional information.
A comprehensive study found that people with fatty liver disease have almost twice the mortality rate of the general population. The disease is caused by overweight or obesity and increases the risk of dying from various causes, including liver disease, cancer, cardiovascular disease, and infections.
New research suggests that maintaining a healthy weight throughout life and losing weight later in life may reduce the risk of kidney cancer. Higher BMI at various ages across adulthood was associated with increased risks of developing different types of kidney cancer, including renal cell carcinoma, papillary RCC, and chromophobe RCC.
A team of biologists has discovered an ancient neurohormone called bombesin that controls appetite in humans and other vertebrates. The study also found that bombesin-like neurohormones are present in starfish, revealing a common ancestor of appetite regulation dating back over half a billion years.
A family-based approach to lifestyle interventions significantly improved weight management and obesity-related health outcomes among individuals with a family history of premature coronary heart disease. The study found that participants experienced an average reduction of 2.61 kg in weight, 1.06 kg/m² in BMI, and 4.17 cm in waist cir...
A study published in The Journal of the National Cancer Institute found that waist circumference is a stronger risk marker than body mass index (BMI) for obesity-related cancers in men. However, this association was not observed in women.
A new study found that new-onset type 2 diabetes is associated with an increased risk of certain obesity-related cancers, such as bowel and pancreatic cancer. The study analyzed data from the UK Biobank and found a 48% increased risk in men and a 24% increased risk in women for overall obesity-related cancers.
More than 20 leading organizations and providers urge the FDA to take action following the recent resolution of GLP-1 medicine shortages. Signatories include the Alliance for Women’s Health & Prevention, Association of Black Cardiologists, and National Hispanic Medical Association.
A Swedish study of over 1,300 participants found that losing a significant amount of weight still offers protection against health issues like cancer and cardiovascular disease, even if some weight is regained. However, regaining weight can increase the risk of microvascular disease and other health problems.
A new study reveals a cell atlas of the endometrium in women with PCOS, showing distinct differences in cellular composition and gene expression. The findings suggest that targeting specific cell types may lead to better treatment options for women with PCOS and related reproductive issues.
A new study in The Journal of Immunology reveals how a high-fat diet can impair the immune system's ability to respond to infection. Male mice fed a high-fat diet exhibited impaired neutrophil function, including reduced bacterial killing capacity and abnormal gene expression.
A study found no increased risk of suicidal events among adults taking GLP-1 receptor agonists for diabetes or obesity, but continued monitoring is warranted to identify at-risk patients. The findings ease concerns about these potential adverse effects, allowing extended use of GLP-1 RAs.
The review explores the pathophysiological mechanisms linking obstructive sleep apnea syndrome and metabolic syndrome, highlighting recent advancements in therapeutic strategies. Treatment approaches aim to break the harmful cycle between OSA and MetS, which affects approximately 14% of the global population.
Research suggests that people with obesity experience a redistribution of their body compartments, such as increased fat trunk accumulation and lower muscle mass, particularly in extremities, as they age. This shift occurs without significant changes in BMI, making it a less useful tool for assessing weight status.
Scientists have discovered a potential new treatment strategy for pancreatic cancer by identifying the molecule Neuropeptide Y (NPY) as a key driver of its spread. Blocking NPY's function has been shown to reduce cancer cell movement and metastatic outgrowth, potentially limiting disease progression.
Tirzepatide and semaglutide offer substantial long-term health benefits in US adults, reducing obesity risk. However, the high costs of these medications make them not cost-effective at current net prices, hindering equitable access.
Media professionals can register for ENDO 2025 to discuss groundbreaking research on obesity, diabetes, and more with world-renowned experts. The event features nearly 2,500 abstracts and over 200 sessions, offering a premier global conference in endocrinology research and clinical care.
A national survey found that nearly 90% of Americans believe eating healthy foods is crucial for preventing conditions like obesity and type-2 diabetes. More than half would participate in produce prescriptions or medically tailored meal programs if offered through their healthcare providers.
A recent study published in Heart journal found that extreme weight fluctuations significantly increase the risk of death among obese individuals with cardiovascular disease. Both weight loss and gain above 10kg raise mortality risk, highlighting the importance of maintaining a stable weight even within the obese range.
A cohort study found that healthier diets and lower waist-to-hip ratios were associated with improved brain connectivity and memory in older adults. The study suggests that interventions targeting diet and central obesity may be most effective between ages 48 and 70 to promote better cognitive health.
Breast cancer death rates are predicted to increase in EU patients aged 80 years and older, while falling in all other age groups. This is attributed to a lack of regular screening and access to modern treatments.
A new study suggests that chronic stress and an unhealthy diet may work together to fuel the early development of pancreatic cancer. Researchers found that both stress-related neurotransmitters and obesity-related hormones activate a protein called CREB, which is linked to cancer cell growth.
A recent study by Professor Mamas highlights the significant risk of cardiovascular diseases (CVD) in patients with cancer, particularly in aging populations. The review emphasizes the need for early diagnosis and regular monitoring to improve quality of life.
Researchers found that high-fat diets caused significant changes in the brains of aged rats, including inflammatory markers and impaired memory functions, even after only three days. The study suggests that aging and diet-related inflammation may be key factors contributing to age-related memory decline.
Researchers found that dogs carrying the genetic variant DENND1B had higher body fat content, while humans also carry this gene linked to obesity. The study highlights the importance of fundamental brain pathways in regulating appetite and body weight.
A study of 350 patients found that taking semaglutide before bariatric surgery did not increase total weight loss and had similar health outcomes to surgery alone. Researchers suggest a surgery-first strategy may lead to better obesity treatment outcomes.
A new study published in Nutrients found that eating two cups of mango daily can help lower insulin concentration levels and improve insulin sensitivity in overweight or obese adults. The study, conducted at the Illinois Institute of Technology, showed significant reductions in insulin resistance and improved beta-cell function.
A new drug candidate has been developed to target and eliminate senescent cells in the liver, reducing fat buildup and preventing liver damage. The study demonstrates a safer and more effective approach to treating metabolic dysfunction-associated steatotic liver disease (MASLD) and potentially inhibiting liver cancer development.
A new Northwestern Medicine study suggests that muscle injuries heal faster when they occur during the body’s natural waking hours. The findings could have implications for shift workers and may also prove useful in understanding the effects of aging and obesity.